MetaVia

MetaVia Inc. (formerly known as NeuroBo Pharmaceuticals) is a clinical-stage biotechnology company focused on developing and commercializing multimodal disease-modifying therapies for viral, neuropathic, and neurodegenerative diseases, with a current portfolio of four drug candidates.On November 29, 2024, NeuroBo Pharmaceuticals, Inc. officially changed its name to MetaVia Inc.